Metabolic signalling
Retatrutida
Retatrutide acts on three receptors at once (GLP-1, GIP and glucagon), one more than tirzepatide. Comes as a powder, in 20 mg and 30 mg vials: mix with bacteriostatic water, inject with an insulin syringe, and keep refrigerated once prepared.
Product details
- Variant
- Retatrutida 30mg
- Category
- Metabolic signalling
Technical references
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist
National Library of Medicine, PubMed
Limits and notices
- AVEON does not recommend dose or treatment. Before use, talk to someone who understands protocol: